Literature DB >> 4003196

Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs.

C P Page, R H Tomiak, S Sanjar, J Morley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4003196     DOI： 10.1007/bf01999637

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  9 in total

1.  The platelet in asthma.

Authors:  J Morley; S Sanjar; C P Page
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

2.  Actions of locally administered adrenoceptor agonists on increased plasma protein extravasation and blood flow in guinea-pig skin.

Authors:  J L Beets; W Paul
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

3.  Platelets and bronchospasm.

Authors:  C P Page; W Paul; J Morley
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

4.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

5.  Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether).

Authors:  B B Vargaftig; J Lefort; F Wal; M Chignard; M C Medeiros
Journal:  Eur J Pharmacol       Date:  1982-08-27       Impact factor: 4.432

6.  Acute effects of intratracheal administration of platelet-activating factor in baboons.

Authors:  A Denjean; B Arnoux; R Masse; A Lockhart; J Benveniste
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-09

7.  Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.

Authors:  M Halonen; J D Palmer; I C Lohman; L M McManus; R N Pinckard
Journal:  Am Rev Respir Dis       Date:  1981-10

8.  Prostaglandin production by macrophages and the effect of anti-inflammatory drugs.

Authors:  M A Bray; D Gordon
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

9.  Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.

Authors:  M Chignard; F Wal; J Lefort; B B Vargaftig
Journal:  Eur J Pharmacol       Date:  1982-02-19       Impact factor: 4.432
  9 in total
  2 in total

1.  Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.

Authors:  F P Nijkamp; G Folkerts; J R Beetens; F De Clerck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

2.  Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis.

Authors:  J L Macpherson; A Kemp; M Rogers; A I Mallet; R F Toia; B Spur; J W Earl; C N Chesterman; S A Krilis
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.